Navigating Inbound Trade & Investment: Strategies for Medtech in the Era of Tariffs & Trade Legal and Policy Shifts 

Navigating Inbound Trade & Investment: Strategies for Medtech in the Era of Tariffs & Trade Policy Shifts 

As trade policies continue to evolve, medical technology companies must stay ahead of shifting tariffs, investment regulations, and compliance requirements. This CLE-accredited session, led by experts from Akin Gump, will provide critical insights into the latest inbound trade and investment challenges. The discussion will explore the impact of current and anticipated U.S. trade policies, including potential shifts under the Trump Administration, and practical strategies medtech organizations can implement to assess risks and navigate regulatory complexities. 

Key Takeaways: 

• Legal & Regulatory Considerations – Explore key legal implications for medtech businesses engaging in international trade. 

• Understand the Evolving Trade Legal and Policy Environment – Gain insights into current and emerging trade and tariff legal issues impacting inbound investment. 

• Risk Assessment & Compliance – Learn how to identify potential trade law risks and ensure compliance with evolving legal standards. 

• Strategic Adaptation – Discover best practices for adjusting legal strategies and investment decisions amid policy shifts. 

• Expert Guidance & Insights – Benefit from the expertise of top trade attorneys from Akin Gump. 

Who Should Attend

In House Legal counsel and compliance officers in the medtech industry 

• Executives and professionals navigating evolving trade legal and policy shifts 

• Executives and decision-makers in medical technology companies 

• Attorneys seeking CLE credit while staying ahead of key industry regulations 

This is a must-attend session for legal professionals, compliance officers, and executives in the medtech industry looking to stay ahead of trade policy changes and mitigate risks effectively.  for policy recommendations. 

Date: March 19, 2025
Time: 1:00 – 2:00 PM ET
Location: Online
CLE Sponsor: Akin Gump Strauss Hauer & Feld LLP
CLE Credit Hour: 1.0

Pricing

AdvaMed® Member: Complimentary (FREE)
Non-AdvaMed® Members: $149 

Check to see if your company is an AdvaMed® member here. 

CLE Information

AdvaMed® Legal and Akin have an arrangement to bring virtual CLE sessions to AdvaMed® comany in house legal teams in 2025 addressing the cutting-edge legal issues in house medtech attorneys need to know in today’s environment. Akin will arrange the CLE. 
 
Akin is an accredited/approved CLE provider in California, New York, and Texas.  There are some states that offer reciprocity with these states:  Alaska, Arkansas, Connecticut, Florida, Hawaii, Montana, New Jersey, and North Dakota.   Akin’s procedure is to provide Uniform CLE Certificates of Attendance to attendees for other states to assist attending attorneys from other states in a self-application process. 

Meet Our Speakers

Suzanne Kane, Partner, International Trade, Akin Gump Strauss Hauer & Feld LLP. Specializing in corporate transactions, mergers and acquisitions, and private equity. With extensive experience advising clients across various industries, she focuses on complex business combinations and strategic investments. Suzanne’s practice encompasses cross-border transactions, corporate governance, and compliance matters, providing clients with comprehensive legal guidance. Her

Sally Laing, Partner, International Trade, Akin Gump Strauss Hauer & Feld LLP. Drawing on 15 years of executive branch, congressional and private practice experience, Sally advises clients on the intersection of international trade law and U.S. public policy. In this capacity, she guides clients through complex strategic decisions regarding regulatory compliance, supply chain resiliency and overcoming trade barriers. Leveraging experience as a senior government official, Sally is able to counsel clients on cutting-edge trade issues, industrial policy and other emerging challenges.

Sarah B. Williamson, Partner, Trade Policy and Compliance, Akin Gump Strauss Hauer & Feld LLP. Focusing on corporate and securities law. She represents clients in capital markets transactions, mergers and acquisitions, and corporate governance matters. Sarah advises public and private companies on securities offerings, compliance with SEC regulations, and disclosure obligations. Her experience includes guiding clients through complex financial transactions and providing strategic counsel on regulatory issues.

Nathan A. Brown Partner, FDA Regulatory, Akin Gump Strauss Hauer & Feld LLP. Specializing in health care regulatory and policy matters. He provides counsel on FDA regulatory issues, compliance strategies, and legislative initiatives affecting the health care sector. Nathan’s practice includes advising clients on product approvals, labeling, and promotional practices. He also assists in navigating the regulatory landscape for pharmaceuticals, medical devices, and biotechnology products.